127 related articles for article (PubMed ID: 9327246)
1. Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals.
Bello H; Gonzalez G; Dominguez M; Zemelman R; Garcia A; Mella S
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):183-6. PubMed ID: 9327246
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial resistance of different Acinetobacter baumannii biotypes isolated in the northern region of Chile].
Silva J; Avello C; Matamoro F; Villagra L; Rojas V; Sandoval L
Rev Med Chil; 1999 Aug; 127(8):926-34. PubMed ID: 10752253
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii.
Martinez-Martinez L; Rodriguez G; Pascual A; Suárez AI; Perea EJ
J Antimicrob Chemother; 1996 Dec; 38(6):1107-8. PubMed ID: 9023661
[No Abstract] [Full Text] [Related]
4. Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.
Zemelman R; Bello H; Dominguez M; Gonzalez G; Mella S; Garcia A
J Antimicrob Chemother; 1993 Sep; 32(3):413-9. PubMed ID: 8262863
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong.
Ling TK; Ying CM; Lee CC; Liu ZK
Med Princ Pract; 2005; 14(5):338-41. PubMed ID: 16103700
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus.
Chow AW; Wong J; Bartlett KH
Diagn Microbiol Infect Dis; 1988 Apr; 9(4):213-7. PubMed ID: 3180706
[TBL] [Abstract][Full Text] [Related]
7. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup.
Capoor MR; Nair D; Srivastava L; Gupta B; Aggarwal P
J Commun Dis; 2005 Jun; 37(2):99-107. PubMed ID: 16749272
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
[TBL] [Abstract][Full Text] [Related]
9. Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units.
Liu PY; Lau YJ; Hu BS; Shyr JM; Shi ZY; Tsai WS; Lin YH; Tseng CY
Diagn Microbiol Infect Dis; 1995 Jul; 22(3):285-91. PubMed ID: 8565418
[TBL] [Abstract][Full Text] [Related]
10. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.
Tatman-Otkun M; Gürcan S; Ozer B; Shokrylanbaran N
New Microbiol; 2004 Jan; 27(1):21-8. PubMed ID: 14964402
[TBL] [Abstract][Full Text] [Related]
11. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
12. A study of the relationships between antibiotic resistance phenotypes, phage-typing and biotyping of 117 clinical isolates of Acinetobacter spp.
Joly-Guillou ML; Bergogne-Berezin E; Vieu JF
J Hosp Infect; 1990 Jul; 16(1):49-58. PubMed ID: 1974906
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY
Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
Tessier F; Quentin C
Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
[TBL] [Abstract][Full Text] [Related]
15. In vitro interactions of aminoglycosides with imipenem or ciprofloxacin against aminoglycoside resistant Acinetobacter baumannii.
Xirouchaki E; Giamarellou H
J Chemother; 1992 Oct; 4(5):263-7. PubMed ID: 1479414
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of antimicrobial agents, alone and in combination, against Acinetobacter baumannii isolated from blood.
Chang SC; Chen YC; Luh KT; Hsieh WC
Diagn Microbiol Infect Dis; 1995 Nov; 23(3):105-110. PubMed ID: 8849654
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Biedenbach DJ; Giao PT; Hung Van P; Su Minh Tuyet N; Thi Thanh Nga T; Phuong DM; Vu Trung N; Badal RE
Clin Ther; 2016 Sep; 38(9):2098-105. PubMed ID: 27612610
[TBL] [Abstract][Full Text] [Related]
18. Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel.
Simhon A; Rahav G; Shazberg G; Block C; Bercovier H; Shapiro M
J Clin Microbiol; 2001 Jan; 39(1):389-91. PubMed ID: 11136809
[TBL] [Abstract][Full Text] [Related]
19. Identification and biotyping of Acinetobacter spp. isolated in Chilean hospitals.
Dominguez M; Gonzalez G; Bello H; Garcia A; Mella S; Pinto ME; Martinez MA; Zemelman R
J Hosp Infect; 1995 Aug; 30(4):267-71. PubMed ID: 7499807
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
Singkham-In U; Chatsuwan T
Diagn Microbiol Infect Dis; 2018 Jun; 91(2):169-174. PubMed ID: 29433997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
